International Immunology, Vol. 14, No. 11, pp. 1351-1356,
November 2002
© 2002 Japanese Society for Immunology
IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells
1 INSRM U454, CHU Arnaud de Villeneuve, 371, Avenue Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France 2 IBMIG, CNRS FRE 2224, 40 Avenue du Recteur Pineau, 86022 Poitiers Cedex, France 3 Institut Génétique Moléculaire, UMR 5535, 1919 Route de Mende, 34033 Montpellier Cedex 1, Montpellier, France
The first two authors contributed equally to this work
Correspondence to: H. Yssel; E-mail: yssel{at}montp.inserm.fr
Transmitting editor: J. Borst
IL-22 is an IL-10 homologue that binds to and signals via the class II cytokine receptor (R) heterodimer IL-22RA1/CFR2-4 (IL-10R2), the latter chain being part of the IL-10R complex. Here, we report that, despite its structural similarity with IL-10, as well as its use of the common IL-10R2 chain, IL-22, in contrast to IL-10, is unable to induce Ig production by activated human B cells. Whereas culture of anti-CD40 mAb-stimulated splenic or tonsillar B cells in the presence of rIL-10 resulted in the production of IgG, IgG1, IgG3 and IgA, rIL-22, at concentrations ranging from 4 to 100 ng/ml, did not induce the production of any of these isotypes. Moreover, unlike rIL-10 which enhanced rIL-4-induced IgG4 and IgE production, rIL-22 was ineffective. Although activated B cells expressed transcripts for a soluble IL-22-binding protein (IL-22RA2), no mRNA for a transmembrane IL-22R (IL-22RA1) could be detected. The latter result was confirmed by the demonstration that rIL-22 failed to induce activation of STAT-3 and -5 in resting or activated B cells. Together, these data show that IL-22, in contrast to its homologue IL-10, is not involved in the immunological activity of B cells, which is due to the absence of a functional IL-22R at the surface of these cells.
Keywords: B cell, ELISA, IL-10, IL-12, signal transduction, Western blotting
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. T. Avery, C. S. Ma, V. L. Bryant, B. Santner-Nanan, R. Nanan, M. Wong, D. A. Fulcher, M. C. Cook, and S. G. Tangye STAT3 is required for IL-21-induced secretion of IgE from human naive B cells Blood, September 1, 2008; 112(5): 1784 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Strle, R. H. McCusker, R. W. Johnson, S. M. Zunich, R. Dantzer, and K. W. Kelley Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1{beta} Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E709 - E718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pene, L. Guglielmi, J.-F. Gauchat, N. Harrer, M. Woisetschlager, V. Boulay, J.-M. Fabre, P. Demoly, and H. Yssel IFN-{gamma}-Mediated Inhibition of Human IgE Synthesis by IL-21 Is Associated with a Polymorphism in the IL-21R Gene J. Immunol., October 15, 2006; 177(8): 5006 - 5013. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Boniface, F.-X. Bernard, M. Garcia, A. L. Gurney, J.-C. Lecron, and F. Morel IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes J. Immunol., March 15, 2005; 174(6): 3695 - 3702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Lozier, N. Tayebi, and P. Zhang Mapping of genes that control the antibody response to human factor IX in mice Blood, February 1, 2005; 105(3): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pene, J.-F. Gauchat, S. Lecart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J.-C. Lecron, and H. Yssel Cutting Edge: IL-21 Is a Switch Factor for the Production of IgG1 and IgG3 by Human B Cells J. Immunol., May 1, 2004; 172(9): 5154 - 5157. [Abstract] [Full Text] [PDF] |
||||


